NPS Pharma (NPSP) Receives FDA Approval of Natpara to Control Hypocalcemia in Hypoparathyroidism Patients
Tweet Send to a Friend
NPS Pharmaceuticals (Nasdaq: NPSP) announced that the U.S. Food and Drug Administration (FDA) has approved Natpara (parathyroid hormone) as an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
